MOG and myeloid sarcoma: A significant defect in the suppressive function of nTregs was first demonstrated in RR MS [49] and was further confirmed by a lower inhibitory effect of Tregs from MS patients on Ag-specific T cell proliferation induced by recombinant MOG and allogenic stimuli [51].